Date: 2013-09-05
Type of information: Grant
Company: Piqur Therapeutics (Switzerland)
Investors: European Eurostars Programme (EU)
Amount:
Funding type: grant and seed financing round
Planned used:
Others: * On September 5, 2013, PIQUR Therapeutics, focused on the discovery and development of innovative anti-cancer drugs, has announced that is has successfully closed a third seed financing round. The private placement was oversubscribed in a very short time frame and included new investors from the life science sector as well as existing shareholders. In addition PIQUR was recently awarded a substantial grant from Eurostars for the further development of its front-runner compound PQR309. PIQUR applied for the Eurostars project jointly with WIL Research Europe (the Netherlands). In Switzerland the project will be funded by the State Secretariat for Education, Research and Innovation and in the Netherlands by the NL Agency.
Therapeutic area: Cancer - Oncology
